Sign In
Last checked at 
11 Mar 2013 07:00
Surgical Innovations Group plc
("SI" or the "Company")
US appointment to the International Clinical Advisory Board
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces the appointment of US Paediatric and Thoracic surgeon Sean Barnett to its International Clinical Advisory Board ('ICAB') with immediate effect.
Sean Barnett, MD, MS, FAAP, FACS, is a US Paediatric and Thoracic surgeon specialising in core trauma and bariatric surgery. He graduated from the University of Purdue, Indiana in 1993 and currently works for one of the largest children's hospital in the US, Cincinnati Children's Hospital Medical Centre.
The ICAB complements the established UK CAB and Sean will be the first paediatric surgeon to be joining either Board. SI are looking to penetrate the paediatric market this coming year with an advanced range of innovative 3mm laparoscopic devices, aimed at all areas of general surgery and especially minimally invasive surgery in children. Having Sean on the Board as a key US Opinion Leader will strengthen SI's US position in this specific area of surgery.
The ICAB will work with key UK and global clinicians to identify their clinical needs as well as being involved in all aspects of the product design cycle.
Graham Bowland, Chief Executive Office for Surgical Innovations, said: "I am delighted to welcome Sean to the ICAB. Sean's expertise in paediatric surgery will help SI focus in this specialist area. SI have a wealth of experience on the UK CAB and are hoping to mirror this in the coming years with the ICAB, to include key opinion leaders in different specialties of MIS from our strategic overseas markets."
- ENDS -
Enquiries:
Surgical Innovations Group plc | www.sigroupplc.com |
Doug Liversidge, Non-Executive Chairman | Tel: +44 (0) 113 230 7597 |
Graham Bowland, Chief Executive Officer | graham.bowland@surginno.co.uk |
|
|
Seymour Pierce | www.cantor.com |
Mark Percy (Corporate Finance) | Tel: +44 (0) 20 7107 8000 |
David Banks (Corporate Broking) |
|
|
|
Walbrook PR Ltd | Tel: +44 (0) 20 7933 8780 |
Paul McManus | Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com |
Lianne Cawthorne | Mob: 07584 391 303 or lianne.cawthorne@walbrookpr.com |
Notes to Editors:
About Surgical Innovations Group plc
Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets.
As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.
Over 120 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.
The Group's patented products are sold through three main channels:
SI brand | Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent.
|
OEM and IP | The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees. Clients include Teleflex Medical, Olympus and CareFusion.
|
Industrial
| SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime.
|
For more information, see www.sigrouplplc.com
Follow the stocks
